Laurus Labs Board of Directors
Get the latest insights into the leadership at Laurus Labs. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| G Venkateswar Reddy | Company Secretary & Compliance Officer |
| Ravindranath Kancherla | Chairman |
| Satyanarayana Chava | Whole Time Director & Chief Executive Officer |
| V Ravi Kumar | Whole Time Director & Chief Financial Officer |
| CV Lakshmana Rao | Executive Director - Quality |
| Krishna Chaitanya Chava | Executive Director - Synthesis |
| Soumya Chava | Executive Director - Generics |
| Aruna Bhinge | Non Executive Independent Director |
| Rajesh Koshy Chandy | Non Executive Independent Director |
| Karnam Sekar | Non Executive Independent Director |
| Ramesh Subrahmanian | Non Executive Independent Director |
Laurus Labs FAQs
The board at Laurus Labs consists of experienced professionals, including G Venkateswar Reddy, Ravindranath Kancherla, and others, overseeing the company’s strategic and corporate governance.
Directors at Laurus Labs are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, G Venkateswar Reddy is the current chairman at Laurus Labs.
Executive directors at Laurus Labs are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Laurus Labs adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Laurus Labs, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
